DE60114362D1 - Verwendung eines zyklischen ethers zur herstellung von mitteln, die die glukosetoleranz beeinflussen - Google Patents

Verwendung eines zyklischen ethers zur herstellung von mitteln, die die glukosetoleranz beeinflussen

Info

Publication number
DE60114362D1
DE60114362D1 DE60114362T DE60114362T DE60114362D1 DE 60114362 D1 DE60114362 D1 DE 60114362D1 DE 60114362 T DE60114362 T DE 60114362T DE 60114362 T DE60114362 T DE 60114362T DE 60114362 D1 DE60114362 D1 DE 60114362D1
Authority
DE
Germany
Prior art keywords
glucose tolerance
cyclic ether
agents
production
influence glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60114362T
Other languages
English (en)
Other versions
DE60114362T2 (de
Inventor
Bo Ahren
Shukun Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DuPont Nutrition Biosciences ApS
Original Assignee
Danisco AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco AS filed Critical Danisco AS
Publication of DE60114362D1 publication Critical patent/DE60114362D1/de
Application granted granted Critical
Publication of DE60114362T2 publication Critical patent/DE60114362T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
DE60114362T 2000-01-14 2001-01-12 Verwendung eines zyklischen ethers zur herstellung von mitteln, die die glukosetoleranz beeinflussen Expired - Lifetime DE60114362T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0000888A GB2358137B (en) 2000-01-14 2000-01-14 Compound
GB0000888 2000-01-14
PCT/IB2001/000139 WO2001051058A1 (en) 2000-01-14 2001-01-12 Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance

Publications (2)

Publication Number Publication Date
DE60114362D1 true DE60114362D1 (de) 2005-12-01
DE60114362T2 DE60114362T2 (de) 2006-07-06

Family

ID=9883727

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60114362T Expired - Lifetime DE60114362T2 (de) 2000-01-14 2001-01-12 Verwendung eines zyklischen ethers zur herstellung von mitteln, die die glukosetoleranz beeinflussen

Country Status (12)

Country Link
US (1) US20020198158A1 (de)
EP (1) EP1246626B1 (de)
JP (1) JP2003519660A (de)
KR (1) KR100804622B1 (de)
CN (1) CN1208066C (de)
AT (1) ATE307598T1 (de)
AU (1) AU783221B2 (de)
BR (1) BR0107160A (de)
CA (1) CA2383158A1 (de)
DE (1) DE60114362T2 (de)
GB (1) GB2358137B (de)
WO (1) WO2001051058A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004509634A (ja) * 2000-09-27 2004-04-02 ダニスコ　エイ／エス 抗菌剤
WO2003037906A1 (en) * 2001-10-31 2003-05-08 Danisco A/S Antimicrobial use of anhydrofructose derivatives
IL152397A (en) 2002-10-21 2009-02-11 Hadasit Med Res Service Compositions and compounds for the treatment of hyperglycemia
EP1686122B1 (de) * 2003-10-28 2012-11-21 Nihon Starch Co., Ltd. Antitumorales mittel
WO2005121114A2 (en) * 2004-06-07 2005-12-22 Glycom Aps 1,5 and 1,4-anhydroketoses, methods for the preparation of 1,5-and 1,4-anhydroketoses, intermediates, and uses of 1,5-and 1,4-anhydroketoses
JP4825957B2 (ja) * 2005-03-29 2011-11-30 国立大学法人 鹿児島大学 抗腫瘍剤
JP5229854B2 (ja) * 2007-02-09 2013-07-03 日本澱粉工業株式会社 動脈硬化症の予防または改善剤
JP5637865B2 (ja) * 2009-01-19 2014-12-10 国立大学法人富山大学 １，５−ａｇ含有組成物
JP2012001515A (ja) * 2010-06-21 2012-01-05 Toyama Univ グリコーゲン分解酵素阻害剤
WO2016171165A1 (ja) * 2015-04-21 2016-10-27 国立大学法人鹿児島大学 カスパーゼ１活性化阻害剤
JP7185226B2 (ja) * 2018-11-22 2022-12-07 国立大学法人 鹿児島大学 １，５－アンヒドロフルクトース誘導体を含むａｍｐｋ活性化剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6279780A (ja) * 1985-05-28 1987-04-13 Nippon Kayaku Co Ltd １，５―アンヒドログルシトールの定量法
JPH0665080A (ja) * 1992-03-10 1994-03-08 Godo Shiyusei Kk α−グルコシダ−ゼ阻害剤を含有する、過血糖付随疾患の予防・治療剤、および保健食

Also Published As

Publication number Publication date
EP1246626B1 (de) 2005-10-26
EP1246626A1 (de) 2002-10-09
JP2003519660A (ja) 2003-06-24
CN1394142A (zh) 2003-01-29
GB2358137A (en) 2001-07-18
AU783221B2 (en) 2005-10-06
ATE307598T1 (de) 2005-11-15
GB0000888D0 (en) 2000-03-08
DE60114362T2 (de) 2006-07-06
CA2383158A1 (en) 2001-07-19
KR100804622B1 (ko) 2008-02-20
BR0107160A (pt) 2002-06-18
GB2358137B (en) 2004-06-09
US20020198158A1 (en) 2002-12-26
WO2001051058A1 (en) 2001-07-19
KR20020032616A (ko) 2002-05-03
CN1208066C (zh) 2005-06-29
AU2700501A (en) 2001-07-24

Similar Documents

Publication Publication Date Title
YU91002A (sh) Derivati acilfenil-karbamida, postupak za njihovu proizvodnju i njihova primena kao leka
BR0317091A (pt) Processo para preparação de 1-olefinas através da dissociação catalìtica de 1-alcoxialcanos
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
BR0010768A (pt) Processo de preparação de "alfa"-metilenolactonas
DE60114362D1 (de) Verwendung eines zyklischen ethers zur herstellung von mitteln, die die glukosetoleranz beeinflussen
SG170081A1 (en) Method of patterning and product(s) obtained therefrom
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
PL1831239T3 (pl) Sposób wytwarzania gamma-laktonu kwasu 17-hydroksy-6 beta, 7 beta,15 beta, 16 beta-bismetyleno-17 alpha-pregn-4-en-3-ono-21-karboksylowego i związki pośrednie kluczowe dla tego sposobu
DE502005011199D1 (de) Herstellung eines von willenbrand faktor-präparates mit hoher spezifischer aktivität
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
DE602004023105D1 (de) HERSTELLUNG VON 4,5-DIALKYL-3-ACYLPYRROL-2-CARBONS ANSCHLIEßENDE ACYLIERUNG
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
MXPA05011193A (es) Compuestos iniciales para producir poliuretanos.
BG104034A (en) Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect
ATE462687T1 (de) Verfahren zur herstellung von azoverbindungen
TW200718705A (en) Processes for the preparation of docetaxel
DE60103560D1 (de) Prozess zur herstellung von paclitaxel
BR0316245A (pt) Atividade antimicrobiana de espécie de oxigênio reativo produtora de anticorpos
DE60236303D1 (de) Verfahren zur herstellung von 14-beta-hydroxybaccatin-iii-1,14-carbonat
ECSP003761A (es) Compuestos heterociclicos sililados
ATE537160T1 (de) Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
ATE274909T1 (de) Verwendung von alprostadil (prostaglandin e1) zur herstellung eines arzneimittels für angioneogenese
MXPA03003466A (es) Derivados de piranosido.
ATE345124T1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1246626

Country of ref document: EP

Representative=s name: WSL PATENTANWAELTE PARTNERSCHAFTSGESELLSCHAFT, DE

R081 Change of applicant/patentee

Ref document number: 1246626

Country of ref document: EP

Owner name: DUPONT NUTRITION BIOSCIENCES APS, DK

Free format text: FORMER OWNER: DANISCO A/S, KOPENHAGEN/KOEBENHAVN, DK

Effective date: 20120821

R082 Change of representative

Ref document number: 1246626

Country of ref document: EP

Representative=s name: WSL PATENTANWAELTE PARTNERSCHAFTSGESELLSCHAFT, DE

Effective date: 20120821